Your browser doesn't support javascript.
loading
PR1 peptide vaccine induces specific immunity with clinical responses in myeloid malignancies.
Qazilbash, M H; Wieder, E; Thall, P F; Wang, X; Rios, R; Lu, S; Kanodia, S; Ruisaard, K E; Giralt, S A; Estey, E H; Cortes, J; Komanduri, K V; Clise-Dwyer, K; Alatrash, G; Ma, Q; Champlin, R E; Molldrem, J J.
Afiliação
  • Qazilbash MH; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wieder E; Adult Stem Cell Transplant Program and Department of Medicine, University of Miami Sylvester Cancer Center, Miami, FL, USA.
  • Thall PF; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wang X; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Rios R; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lu S; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kanodia S; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ruisaard KE; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Giralt SA; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • Estey EH; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Cortes J; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Komanduri KV; Adult Stem Cell Transplant Program and Department of Medicine, University of Miami Sylvester Cancer Center, Miami, FL, USA.
  • Clise-Dwyer K; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Alatrash G; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ma Q; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Champlin RE; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Molldrem JJ; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Leukemia ; 31(3): 697-704, 2017 03.
Article em En | MEDLINE | ID: mdl-27654852
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos / Leucemia Mielogênica Crônica BCR-ABL Positiva / Leucemia Mieloide Aguda / Antígeno HLA-A2 / Vacinas Anticâncer Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos / Leucemia Mielogênica Crônica BCR-ABL Positiva / Leucemia Mieloide Aguda / Antígeno HLA-A2 / Vacinas Anticâncer Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article